Filing metadata

Accession number
0001415889-25-022459
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Aug 20, 2025
Reporting period
Aug 18, 2025
Description
Insider transaction

Explore SEC Filings Hub